Having acquired a 72 per cent stake in Fem Care Pharma, homegrown FMCG company Dabur India is all set to change the brand structure of its skin care category to accommodate the recently-acquired brands.
Fem will now join the ranks of Dabur, Vatika, Real and Hajmola as the fifth master brand in Dabur’s portfolio. It will continue to operate as a separate subsidiary of Dabur and will subsequently be merged into the company, Dabur India Chief Executive Officer Sunil Duggal told analysts. Fem Care’s over-the-counter (OTC) business will be channelised into Dabur’s consumer healthcare division.
Dabur is targeting an entry into the high-growth skin-care market with Fem Care’s portfolio, which includes products such as fairness bleach, hair remover and liquid soap. The company has only a minor presence in the segment with Gulabari and Vatika brands.
Despite the acquisition, Dabur plans to launch a new ayurvedic skin care brand by the first quarter of FY10 to cater to the mass prestige category. Speaking to the analysts about the changes, Duggal said, “Our independent ayurvedic skin care brand is under development though the launch may be delayed for a few months as we are assessing the synergies for renewing our brand architecture.” He, however, did not reveal investments lined up for the same.
“There is a huge potential to scale up the Fem portfolio,” Duggal said. The new ayurvedic skin care brand will form the third rung of the skin care vertical and will operate in the ‘masstige’ (mass prestige) category allowing Dabur to have a portfolio across price segments.
Further, Dabur hopes to capitalise on Fem Care’s channel presence in domestic and international markets. It can now promote its core brand Vatika in a network of over 25,000 parlours in India where Fem has a significant presence.
“Valuation for the deal is somewhat expensive given the market conditions, but Dabur had been scouting for opportunities to enter the skin care market for a while. The benefits of buying an established brand with strong market presence will balance out the cost for the company in the long run since margins for the products are higher,” said Anand Shah, sector analyst with Angel Broking.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
